Canadian biotech Morphocell Technologies has completed its series A at $50 million after a $10 million extension led by ...

US Food and Drug Administration staff are bracing for a sweeping shift in vaccine oversight after Vinay Prasad, head of the ...

UK-based NRG Therapeutics has announced the expansion of its team with the appointment of Paul Thompson as chief development ...

The board of directors of the Greek pharma trade group SFEE last week presented to the leadership of the Ministry of Health ...

Swedish-Dutch biopharma Mendus, a company focused on immunotherapies targeting tumor recurrence, has announced the successful ...

A new agreement between the Danish government, Danske Regioner and KL sets the course for implementing Cancer Plan V, the ...

India’s pharmaceutical recalls are drawing global attention, as the US Food and Drug Administration (FDA) recently announced ...

Recipharm Advanced Bio, part of Sweden-headquartered Recipharm contract development and manufacturing organization (CDMO), ...

Pulmonary arterial hypertension (PAH) is a rare, progressive, and often fatal cardiopulmonary condition characterized by pulmonary vascular remodeling and progressive narrowing, leading to increased ...

International understanding of China’s arrival as a leading player on the world stage as an innovator of new medicines is now ...

Important regulatory news last week included Otsuka gaining accelerated Food and Drug Administration approval for its Voyxact (sibeprenlimab) for immunoglobulin A nephrology, India’s Sun Pharma for ...

India’s pharmaceutical sector is witnessing global majors deepening their footprint in advanced therapies. The Central Drugs ...